Keyphrases
Adverse Effects
33%
Attention Deficit Hyperactivity Disorder
100%
Attention-deficit Hyperactivity Disorder Symptoms
16%
Children with Attention Deficit
100%
Clinical Global Impression Scale
16%
Conners Rating Scales
16%
Long-term Efficacy
33%
Long-term Safety
16%
Long-term Tolerability
16%
Maintenance Treatment
100%
Mean Standard Deviation
16%
Multi-scale Attention
16%
New Onset
16%
Placebo
16%
Rating Scales
16%
Reboxetine
100%
Risk-benefit Ratio
16%
Routine Blood
16%
Suicidal Attempt
16%
Suicidal Ideation
16%
Tolerability
16%
Vital Signs
16%
Medicine and Dentistry
Adverse Effect
28%
Attention Deficit Disorder
100%
Body Weight
14%
Clinical Global Impression
14%
Electrocardiogram
14%
Maintenance Therapy
100%
Placebo
14%
Rating Scale
28%
Reboxetine
100%
Risk-Benefit Ratio
14%
Suicidal Ideation
14%
Suicide Attempt
14%
Vital Sign
14%
Neuroscience
Adverse Effect
28%
Attention Deficit Hyperactivity Disorder
100%
Placebo
14%
Reboxetine
100%
Suicidal Ideation
14%
Suicide Attempt
14%
Pharmacology, Toxicology and Pharmaceutical Science
Attention Deficit Disorder
100%
Placebo
14%
Reboxetine
100%
Suicidal Ideation
14%
Suicide Attempt
14%
Tolerability
28%
Psychology
Attention Deficit Hyperactivity Disorder
100%
Body Weight
14%
Conners Rating Scales
14%
Rating Scale
14%